Related Experiment Video
Updated: May 10, 2026

Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
[Efficiency of endoscopic treatment of primary vesicoureteral reflux depending on bulking agent]
Insights
Endoscopic treatment for vesicoureteral reflux (VUR) in children showed varying success rates with different bulking agents. Vantris is recommended as a safe and effective option for VUR treatment.
Area of Science:
- Pediatric Urology
- Minimally Invasive Surgery
- Biomaterials in Medicine
Background:
- Vesicoureteral reflux (VUR) is a common condition in children.
- Endoscopic treatment offers a minimally invasive approach to VUR management.
- Various bulking agents have been utilized for endoscopic VUR correction.
Purpose of the Study:
- To compare the effectiveness of different bulking agents used in endoscopic treatment of primary VUR in children.
- To evaluate the safety and efficacy of Teflon paste, DAM+, Urodex, and Vantris.
- To identify the optimal bulking agent for VUR treatment in pediatric patients.
Main Methods:
- A retrospective study of over 4,000 children undergoing endoscopic VUR treatment from 1991 to 2011.
- Comparative analysis of single endoplasty outcomes using Teflon paste, DAM+, Urodex, and Vantris.
- Inclusion criteria: primary VUR (Grades I-V), absence of major ureteral abnormalities, and no chronic cystitis.
Main Results:
- Teflon paste achieved reflux elimination in 95.3% of cases (107 patients).
- Vantris demonstrated a success rate of 92.9% (56 patients).
- DAM+ and Urodex showed lower efficacy at 77.8% (186 patients) and 68.1% (69 patients), respectively.
Conclusions:
- Vantris is a highly effective bulking agent for endoscopic VUR treatment in children.
- Vantris meets modern safety requirements, making it a recommended option.
- The study highlights the importance of selecting appropriate bulking agents for successful VUR management.
Abstract:
From June 1991 to December 2011, endoscopic treatment of vesicoureteral reflux (VUR) was performed more than in 4,000 children aged 4 months to 17 years. As bulking agents, teflon paste, DAM +, urodex, and vantris were used. A comparative evaluation of the effectiveness of single endoplasty with various bulking agents in children with I-V degree primary VUR, who had no gross congenital abnormalities in ureterovesical anastomosis, such as paraureteral diverticula, complete duplicated ureter or extravesicalisation of ureter, and not suffered from chronic cystitis, was performed. It was found that the use of Teflon paste led to elimination of reflux in 102 (95.3%) of 107 patients, vantris--in 52 (92.9%) of 56 patients, DAM(+)--in 145 (77.8%) of 186, urodex--in 47 (68.1%) of 69 patients. Among modern bulking agents meet all safety requirements, vantris is recommended for the optimal treatment of vesicoureteral reflux in children.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi VI: Surgical Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urologic Endoscopic Procedure: Cystoscopic Examination
Imaging Studies VI: Voiding Cystourethrography and Cystography
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
